This clinical trial aims to evaluate the effectiveness and safety of a new medication for managing diabetes. Participants will be monitored over a period of 12 months to assess the medication's impact on blood sugar levels and overall health.
- Who Can Participate: Adults aged 18-65 with a diagnosis of type 2 diabetes who are not currently on insulin therapy
- Study Details: The study involves taking the medication daily and attending monthly check-ups to monitor health and progress
- Study Timelines and Visits: The study will run for a total of 12 months.Participants are required to attend 12 monthly visits during the study period
